Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

circRNA circARNT2 Suppressed the Sensitivity of Hepatocellular Carcinoma Cells to Cisplatin by Targeting the miR-155-5p/PDK1 Axis
Yueyong Li, Ying‐Jun Zhang, Shuai Zhang, et al.
Molecular Therapy — Nucleic Acids (2020) Vol. 23, pp. 244-254
Open Access | Times Cited: 48

Showing 1-25 of 48 citing articles:

Biological impact and therapeutic perspective of targeting PI3K/Akt signaling in hepatocellular carcinoma: Promises and Challenges
Mahshid Deldar Abad Paskeh, Fatemeh Ghadyani, Mehrdad Hashemi, et al.
Pharmacological Research (2022) Vol. 187, pp. 106553-106553
Open Access | Times Cited: 85
Circ-ZEB1 promotes PIK3CA expression by silencing miR-199a-3p and affects the proliferation and apoptosis of hepatocellular carcinoma
Weiwei Liu, Lu Zheng, Rongguiyi Zhang, et al.
Molecular Cancer (2022) Vol. 21, Iss. 1
Open Access | Times Cited: 73
A novel polypeptide encoded by the circular RNA ZKSCAN1 suppresses HCC via degradation of mTOR
Runjie Song, Shuoqian Ma, Jiajia Xu, et al.
Molecular Cancer (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 72
Curcumin suppresses the malignancy of non-small cell lung cancer by modulating the circ-PRKCA/miR-384/ITGB1 pathway
Xiaoqing Xu, Xinyue Zhang, Yang Zhang, et al.
Biomedicine & Pharmacotherapy (2021) Vol. 138, pp. 111439-111439
Open Access | Times Cited: 50
The functional roles, cross-talk and clinical implications of m6A modification and circRNA in hepatocellular carcinoma
Sha Qin, Yitao Mao, Chen Xue, et al.
International Journal of Biological Sciences (2021) Vol. 17, Iss. 12, pp. 3059-3079
Open Access | Times Cited: 41
Two circPPFIA1s negatively regulate liver metastasis of colon cancer via miR-155-5p/CDX1 and HuR/RAB36
Haein Ji, Tae‐Won Kim, Woo Joo Lee, et al.
Molecular Cancer (2022) Vol. 21, Iss. 1
Open Access | Times Cited: 36
The novel role of circular RNA ST3GAL6 on blocking gastric cancer malignant behaviours through autophagy regulated by the FOXP2/MET/mTOR axis
Penghui Xu, Xing Zhang, Jiacheng Cao, et al.
Clinical and Translational Medicine (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 33
Nanodrugs based on co-delivery strategies to combat cisplatin resistance
Qiubo Wang, Hui Li, Wu Taixia, et al.
Journal of Controlled Release (2024) Vol. 370, pp. 14-42
Closed Access | Times Cited: 7
The Role of Circular RNAs in the Drug Resistance of Cancers
Xinyuan Liu, Qi Zhang, Jing Guo, et al.
Frontiers in Oncology (2022) Vol. 11
Open Access | Times Cited: 25
Circ-PKD2 promotes Atg13-mediated autophagy by inhibiting miR-646 to increase the sensitivity of cisplatin in oral squamous cell carcinomas
Ling Gao, Qian Zhang, Shaoming Li, et al.
Cell Death and Disease (2022) Vol. 13, Iss. 2
Open Access | Times Cited: 23
The interplay between noncoding RNAs and drug resistance in hepatocellular carcinoma: the big impact of little things
Yuan Fang, Xiaoli Zhang, Hanfei Huang, et al.
Journal of Translational Medicine (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 15
Non-coding RNAs in hepatocellular carcinoma: Insights into regulatory mechanisms, clinical significance, and therapeutic potential
Han Qin, Mengchen Wang, Xi Dong, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 20
Hsa_circ_0000098 is a novel therapeutic target that promotes hepatocellular carcinoma development and resistance to doxorubicin
Yi Li, Anqi Wu, Lin Chen, et al.
Journal of Experimental & Clinical Cancer Research (2022) Vol. 41, Iss. 1
Open Access | Times Cited: 19
Circ_0078607 increases platinum drug sensitivity via miR-196b-5p/GAS7 axis in ovarian cancer
Dai Cheng, Shiyuan Dai, Yan Gao, et al.
Epigenetics (2023) Vol. 18, Iss. 1
Open Access | Times Cited: 11
Role of circular RNAs in cancer therapy resistance
Wenjuan Liu, Jiling Niu, Yanfei Huo, et al.
Molecular Cancer (2025) Vol. 24, Iss. 1
Open Access
Recent advances in the role of circRNA in cisplatin resistance in tumors
Jiawen Zhang, Qiwen Yu, Weijin Zhu, et al.
Cancer Gene Therapy (2025)
Closed Access
Noncoding RNAs in triple negative breast cancer: Mechanisms for chemoresistance
Min Xia, Xuyu Zu, Zuyao Chen, et al.
Cancer Letters (2021) Vol. 523, pp. 100-110
Open Access | Times Cited: 26
Crosstalk Between circRNA and Tumor Microenvironment of Hepatocellular Carcinoma: Mechanism, Function and Applications
Chenxi Xie, Xiaopei Hao, Hao Yuan, et al.
OncoTargets and Therapy (2024) Vol. Volume 17, pp. 7-26
Open Access | Times Cited: 3
Cyclin-dependent kinase 1 as a potential target for lycorine against hepatocellular carcinoma
Shuangshuang Yin, Shenshen Yang, Yanming Luo, et al.
Biochemical Pharmacology (2021) Vol. 193, pp. 114806-114806
Closed Access | Times Cited: 23
Circular RNAs in hepatocellular carcinoma: biogenesis, function, and pathology
Guocheng Rao, Peng Xi, Yan Tian, et al.
Frontiers in Genetics (2023) Vol. 14
Open Access | Times Cited: 8
Transcriptome Profiling Reveals B-Lineage Cells Contribute to the Poor Prognosis and Metastasis of Clear Cell Renal Cell Carcinoma
Fafen Yang, Jingjie Zhao, Xiuzhuang Luo, et al.
Frontiers in Oncology (2021) Vol. 11
Open Access | Times Cited: 18
Clinical Significance of Non-Coding RNA Regulation of Programmed Cell Death in Hepatocellular Carcinoma
Wuyu Chen, Minghao Ruan, Minghao Zou, et al.
Cancers (2023) Vol. 15, Iss. 16, pp. 4187-4187
Open Access | Times Cited: 7
Contribution of MicroRNAs in Chemoresistance to Cisplatin in the Top Five Deadliest Cancer: An Updated Review
Pía Loren, Nicolás Saavedra, Kathleen Saavedra, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 12
LncRNA CRNDE is involved in radiation resistance in hepatocellular carcinoma via modulating the SP1/PDK1 axis
Kaiyun Chen, Zhu Shuguang, Ji-wen He, et al.
Neoplasma (2022) Vol. 69, Iss. 04, pp. 918-930
Open Access | Times Cited: 12
Recent research progress of circular RNAs in hepatocellular carcinoma
Zhi-di Li, Yang-ling Li, Jing Lu, et al.
Frontiers in Oncology (2024) Vol. 13
Open Access | Times Cited: 2
Page 1 - Next Page

Scroll to top